International consensus on (ICON) pediatric asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 8, 2012, Pages 976-997

  Papadopoulos, N G ^a   Arakawa, H ^b   Carlsen, K H ^c   Custovic, A ^d   Gern, J ^e   Lemanske, R ^e   Le Souef, P ^f   Makela M ^g   Roberts, G ^h   Wong, G ⁱ   Zar, H ^j   Akdis, C A ^k   Bacharier, L B ^l   Baraldi, E ^m   Van Bever, H P ⁿ   De Blic, J ^o   Boner, A ^p   Burks, W ^q   Casale, T B ^r   Castro Rodriguez, J A ^s   Chen, Y Z ^t   El Gamal, Y M ^u   Everard, M L ^v   Frischer, T ^w   Geller, M ^x   Gereda, J ^y   Goh, D Y ⁿ   Guilbert, T W ^e   Hedlin, G ^z   Heymann, P W ^aa   Hong, S J ^ab   Hossny, E M ^ac   Huang, J L ^ad   Jackson, D J ^e   De Jongste, J C ^ae   Kalayci, O ^af   Ait Khaled N ^ag   Kling, S ^ah   Kuna, P ^ai   Lau, S ^aj   Ledford, D K ^ak   Lee, S I ^al   Liu, A H ^am   Lockey, R F ^ak   Ladrup Carlsen K ^an   Lotvall J ^ao   Morikawa, A ^b   Nieto, A ^ap   Paramesh, H ^aq   Pawankar, R ^ar   Pohunek, P ^as   Pongracic, J ^at   Price, D ^au   Robertson, C ^av   Rosario, N ^aw   Rossenwasser, L J ^ax   Sly, P D ^ay   Stein, R ^az   Stick, S ^ba   Szefler, S ^bb   Taussig, L M ^bc   Valovirta, E ^bd   Vichyanond, P ^be   Wallace, D ^bf   Weinberg, E ^j   Wennergren, G ^ao   Wildhaber, J ^bg   Zeiger, R S ^ag   more..

^a UNIVERSITY OF ATHENS   (Greece)

^b GUNMA UNIVERSITY   (Japan)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF PADOVA   (Italy)

ⁿ NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^o ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^p UNIVERSITY OF VERONA   (Italy)

^q DUKE UNIVERSITY MEDICAL CENTER   (United States)

^r CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^t CAPITAL INSTITUTE OF PEDIATRICS   (China)

^u AIN SHAMS UNIVERSITY   (Egypt)

^v SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^w ST ANNA CHILDREN S HOSPITAL   (Austria)

^x Geller Allergy and Immunology Clinic   (Brazil)

^y CLÍNICA RICARDO PALMA   (Peru)

^z KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^aa UNIVERSITY OF VIRGINIA   (United States)

^ab University of Ulsan   (South Korea)

^ac Ain Shams University   (Egypt)

^ad CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^ae SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^af HACETTEPE UNIVERSITY   (Turkey)

^ag Hacettepe University ^*  (United States)

^ah STELLENBOSCH UNIVERSITY   (South Africa)

^ai N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

^aj CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ak UNIVERSITY OF SOUTH FLORIDA   (United States)

^al Sungkyunkwan University   (South Korea)

^am UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^an ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^ao UNIVERSITY OF GOTHENBURG   (Sweden)

^ap HOSPITAL UNIVERSITARIO LA FE   (Spain)

^aq Lakeside Medical Center and Hospital   (India)

^ar NIPPON MEDICAL SCHOOL   (Japan)

^as CHARLES UNIVERSITY   (Czech Republic)

^at NORTHWESTERN UNIVERSITY   (United States)

^au UNIVERSITY OF ABERDEEN   (United Kingdom)

^av ROYAL CHILDREN'S HOSPITAL   (Australia)

^aw FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^ax CHILDREN S MERCY HOSPITAL   (United States)

^ay UNIVERSITY OF QUEENSLAND   (Australia)

^az PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^ba PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^bb DEPARTMENT OF MEDICINE   (United States)

^bc UNIVERSITY OF DENVER   (United States)

^bd UNIVERSITY OF TURKU   (Finland)

^be MAHIDOL UNIVERSITY   (Thailand)

^bf NOVA SOUTHEASTERN UNIVERSITY   (United States)

^bg UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

more..

Author keywords

Asthma; Children; Consensus; Guidelines; Wheeze

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CHROMONE DERIVATIVE; CICLESONIDE; FLUNISOLIDE; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; OMALIZUMAB; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; VITAMIN D; ZAFIRLUKAST;

ARTICLE; ASTHMA; ATOPY; BRONCHODILATATION; CONSENSUS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; POWDER INHALER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN;

EID: 84863836184     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02865.x     Document Type: Article

References (139)

1. Kupczyk M, Haahtela T, Cruz AA, Kuna P,. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65: 415-419.
2. Lotvall J, Pawankar R, Wallace DV, Akdis CA, Rosenwasser LJ, Weber RW, et al. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. Allergy 2012; 67: 449-450.
3. Asthma Management Handbook. National Asthma Council Australia, Melbourne, 2006. Available from: (accessed March 2011).
4. From the Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2011. Available from:.
5. From the Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger. Global Initiative for Asthma (GINA), 2009. Available from:.
6. Nishimuta T, Kondo N, Hamasaki Y, Morikawa A, Nishima S,. Japanese guideline for childhood asthma. Allergol Int 2011; 60: 147-169.
7. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. Bethesda, MD, USA: National Heart, Lung, and Blood Institute (US), 2007.
8. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Gotz M, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5-34. (Pubitemid 350198248)
9. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A National Clinical Guideline. British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2011. Available from:.
10. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 2000; 320: 537-540. (Pubitemid 30175797)
11. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ 3rd, O'Fallon WM, Silverstein MD,. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am J Respir Crit Care Med 1992; 146: 888-894.
12. Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758-766.
13. Wennergren G, Ekerljung L, Alm B, Eriksson J, Lotvall J, Lundback B,. Asthma in late adolescence-farm childhood is protective and the prevalence increase has levelled off. Pediatr Allergy Immunol 2010; 21: 806-813.
14. Sackesen C, Birben E, Soyer OU, Sahiner UM, Yavuz TS, Civelek E, et al. The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma. Allergy 2011; 66: 48-57.
15. Tesse R, Pandey RC, Kabesch M,. Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy 2011; 66: 307-316.
16. Tischer CG, Hohmann C, Thiering E, Herbarth O, Muller A, Henderson J, et al. Meta-analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative. Allergy 2011; 66: 1570-1579.
17. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ,. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323: 502-507. (Pubitemid 20260050)
18. Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997; 1 (Pt 1) 763-769. (Pubitemid 27280366)
19. Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005; 116: 49-55. (Pubitemid 40909746)
20. Woodcock A, Lowe LA, Murray CS, Simpson BM, Pipis SD, Kissen P, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 2004; 170: 433-439. (Pubitemid 39214619)
21. Horak F Jr, Matthews S, Ihorst G, Arshad SH, Frischer T, Kuehr J, et al. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study-24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy 2004; 34: 1220-1225. (Pubitemid 39093060)
22. Castro-Rodriguez JA, Garcia-Marcos L, Sanchez-Solis M, Perez-Fernandez V, Martinez-Torres A, Mallol J,. Olive oil during pregnancy is associated with reduced wheezing during the first year of life of the offspring. Pediatr Pulmonol 2010; 45: 395-402.
23. Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E,. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy 2012; 67: 10-17.
24. Martinez FD,. New insights into the natural history of asthma: primary prevention on the horizon. J Allergy Clin Immunol 2011; 128: 939-945.
25. Busse WW, Lemanske RF Jr,. Asthma. N Engl J Med 2001; 344: 350-362. (Pubitemid 32107645)
26. Snijders D, Agostini S, Bertuola F, Panizzolo C, Baraldo S, Turato G, et al. Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children. Allergy 2010; 65: 978-985.
27. Holgate ST,. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120: 1233-1244. (Pubitemid 350225687)
28. Chung KF,. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? Eur Respir J 2000; 15: 961-968. (Pubitemid 30321858)
29. Hamid Q, Tulic M,. Immunobiology of asthma. Annu Rev Physiol 2009; 71: 489-507.
30. Robinson DS,. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? J Allergy Clin Immunol 2004; 114: 58-65. (Pubitemid 39005118)
31. Xepapadaki P, Papadopoulos NG, Bossios A, Manoussakis E, Manousakas T, Saxoni-Papageorgiou P,. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 2005; 116: 299-304. (Pubitemid 41096535)
32. Joos GF,. The role of neuroeffector mechanisms in the pathogenesis of asthma. Curr Allergy Asthma Rep 2001; 1: 134-143.
33. Holgate ST, Polosa R,. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368: 780-793. (Pubitemid 44279056)
34. Fixman ED, Stewart A, Martin JG,. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 2007; 29: 379-389. (Pubitemid 46231919)
35. Watelet JB, Van Zele T, Gjomarkaj M, Canonica GW, Dahlen SE, Fokkens W, et al. Tissue remodelling in upper airways: where is the link with lower airway remodelling? Allergy 2006; 61: 1249-1258. (Pubitemid 44465583)
36. Malmstrom K, Pelkonen AS, Malmberg LP, Sarna S, Lindahl H, Kajosaari M, et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax 2011; 66: 157-162.
37. Bossley CJ, Fleming L, Gupta A, Regamey N, Frith J, Oates T, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol 2012; 129: 974-982.
38. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422. (Pubitemid 37211056)
39. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ,. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138.
40. Bisgaard H, Bonnelykke K,. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010; 126: 187-197; quiz 198-189.
41. Covar RA, Strunk R, Zeiger RS, Wilson LA, Liu AH, Weiss S, et al. Predictors of remitting, periodic, and persistent childhood asthma. J Allergy Clin Immunol 2010; 125: 359-366.
42. Ruotsalainen M, Piippo-Savolainen E, Hyvarinen MK, Korppi M,. Adulthood asthma after wheezing in infancy: a questionnaire study at 27 years of age. Allergy 2010; 65: 503-509.
43. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD,. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 1 (Pt 1): 1403-1406.
44. Leonardi NA, Spycher BD, Strippoli MP, Frey U, Silverman M, Kuehni CE,. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol 2011; 127: 1466-1472.
45. Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA,. Discriminative properties of two predictive indices for asthma diagnosis in a sample of preschoolers with recurrent wheezing. Pediatr Pulmonol 2011; 46: 1175-1181.
46. Brand PL,. The Asthma Predictive Index: not a useful tool in clinical practice. J Allergy Clin Immunol 2011; 127: 293-294.
47. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA,. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004; 170: 426-432. (Pubitemid 39214618)
48. Frey U,. Forced oscillation technique in infants and young children. Paediatr Respir Rev 2005; 6: 246-254. (Pubitemid 41722606)
49. Bisgaard H, Nielsen KG,. Plethysmographic measurements of specific airway resistance in young children. Chest 2005; 128: 355-362. (Pubitemid 40994495)
50. Schwartz LB, Delgado L, Craig T, Bonini S, Carlsen KH, Casale TB, et al. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy). Allergy 2008; 63: 953-961.
51. Cockcroft D, Davis B,. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol 2009; 103: 363-369; quiz 369-372, 400.
52. Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U,. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368: 763-770. (Pubitemid 44279054)
53. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
54. Lodrup Carlsen KC, Soderstrom L, Mowinckel P, Haland G, Pettersen M, Munthe Kaas MC, et al. Asthma prediction in school children; the value of combined IgE-antibodies and obstructive airways disease severity score. Allergy 2010; 65: 1134-1140.
55. Pedersen S,. Preschool asthma-not so easy to diagnose. Prim Care Respir J 2007; 16: 4-6.
56. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110.
57. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A,. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368: 754-762. (Pubitemid 44294820)
58. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F,. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998-2005.
59. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-1997.
60. Vahlkvist S, Inman MD, Pedersen S,. Effect of asthma treatment on fitness, daily activity and body composition in children with asthma. Allergy 2010; 65: 1464-1471.
61. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475. (Pubitemid 29372886)
62. Eng PA, Reinhold M, Gnehm HP,. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002; 57: 306-312. (Pubitemid 34280657)
63. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948. (Pubitemid 47037870)
64. Andrade WC, Camargos P, Lasmar L, Bousquet J,. A pediatric asthma management program in a low-income setting resulting in reduced use of health service for acute asthma. Allergy 2010; 65: 1472-1477.
65. Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lodrup Carlsen KC, et al. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Allergy 2010; 65: 681-689.
66. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R, et al.et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004; 351: 1068-1080. (Pubitemid 39167511)
67. Paramesh H,. Asthma in children: seasonal variations. Int J Environ Health 2008; 4: 410-416.
68. Barnes PJ,. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868-875.
69. Zhang L, Axelsson I, Chung M, Lau J,. Dose response of inhaled corticosteroids in children with persistent asthma: a systematic review. Pediatrics 2011; 127: 129-138.
70. Masoli M, Weatherall M, Holt S, Beasley R,. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 2004; 89: 902-907.
71. McKean M, Ducharme F,. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000: CD001107.
72. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343: 1054-1063.
73. Leone FT, Fish JE, Szefler SJ, West SL,. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003; 124: 2329-2340. (Pubitemid 38010606)
74. Guilbert TW, Mauger DT, Allen DB, Zeiger RS, Lemanske RF Jr, Szefler SJ, et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol 2011; 128: 956-963.
75. Strunk RC, Sternberg AL, Szefler SJ, Zeiger RS, Bender B, Tonascia J,. Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009; 154: 682-687.
76. Lipworth BJ,. Leukotriene-receptor antagonists. Lancet 1999; 353: 57-62. (Pubitemid 29037713)
77. Drazen JM, Israel E, O'Byrne PM,. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206. (Pubitemid 29063217)
78. Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011; 364: 1695-1707.
79. Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P,. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005; 116: 360-369. (Pubitemid 44161461)
80. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W, Kuna P,. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008; 121: 383-389. (Pubitemid 351215167)
81. Ram FS, Cates CJ, Ducharme FM,. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2005: CD003137.
82. Woolcock A, Lundback B, Ringdal N, Jacques LA,. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-1488. (Pubitemid 26141329)
83. Greening AP, Ind PW, Northfield M, Shaw G,. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-224. (Pubitemid 24229008)
84. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ,. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 2010: CD005533.
85. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM,. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15-26. (Pubitemid 43265239)
86. McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D,. Age and risks of FDA-approved long-acting beta-adrenergic receptor agonists. Pediatrics 2011; 128: e1147-e1154.
87. Rodrigo GJ, Castro-Rodriguez JA,. Safety of long-acting beta agonists for the treatment of asthma: clearing the air. Thorax 2012; 67: 342-349.
88. Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess 2008; 12: 1-174, iii-iv.
89. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ,. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010: CD005535.
90. Lemanske RF Jr, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362: 975-985.
91. Sears MR,. Safety of long-acting beta-agonists: are new data really required? Chest 2009; 136: 604-607.
92. Lemanske RF Jr, Busse WW,. The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy? J Allergy Clin Immunol 2010; 126: 449-452.
93. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C,. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006; 130: 1733-1743. (Pubitemid 46033427)
94. Edwards AM, Stevens MT,. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J 1993; 6: 35-41. (Pubitemid 23041913)
95. Szefler SJ, Nelson HS,. Alternative agents for anti-inflammatory treatment of asthma. J Allergy Clin Immunol 1998; 2 (Pt 2): S23-S35. (Pubitemid 128717793)
96. Weinberger M, Hendeles L,. Theophylline in asthma. N Engl J Med 1996; 334: 1380-1388. (Pubitemid 26152719)
97. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH,. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006: CD003559.
98. Finn A, Gross G, van Bavel J, Lee T, Windom H, Everhard F, et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 2003; 111: 278-284. (Pubitemid 36228546)
99. Rodrigo GJ, Neffen H, Castro-Rodriguez JA,. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest 2011; 139: 28-35.
100. Kopp MV,. Role of immunmodulators in allergen-specific immunotherapy. Allergy 2011; 66: 792-797.
101. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, et al. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. J Allergy Clin Immunol 2000; 1 (Pt 1): 1123-1129.
102. Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, et al. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. J Allergy Clin Immunol 2001; 107: 461-468. et al. (Pubitemid 32210026)
103. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115: 233-242. (Pubitemid 40215084)
104. Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009; 44: 568-579.
105. Ballardini N, Kull I, Lind T, Hallner E, Almqvist C, Ostblom E, et al. Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy 2012; 67: 537-544.
106. Ait-Khaled N, Enarson DA, Chiang C-Y, Marks G, Bissell K,. Management of Asthma: A Guide to Essentials of Good Practice. Paris, France: International Union Against Tuberculosis and Lung Disease, 2008.
107. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335-371. (Pubitemid 41724594)
108. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331.
109. De Benedictis FM, Selvaggio D,. Use of inhaler devices in pediatric asthma. Paediatr Drugs 2003; 5: 629-638. (Pubitemid 37159617)
110. Castro-Rodriguez JA, Rodrigo GJ,. beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004; 145: 172-177. (Pubitemid 38993387)
111. Cates CJ, Crilly JA, Rowe BH,. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006: CD000052.
112. Pierart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souef PN,. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999; 13: 673-678. (Pubitemid 29180184)
113. Zar HJ, Brown G, Donson H, Brathwaite N, Mann MD, Weinberg EG,. Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial. Lancet 1999; 354: 979-982. (Pubitemid 29438403)
114. Bousquet J, Lockey R, Malling HJ,. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 1 (Pt 1): 558-562.
115. Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P,. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012; 129: 929-934.
116. European Academy of Allergy and Clinical Immunology. European Declaration on Allergen Immunotherapy. European Academy of Allergy and Clinical Immunology, 2011. Available from:.
117. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S,. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-1397. (Pubitemid 32823876)
118. Bernstein DI, Wanner M, Borish L, Liss GM,. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113: 1129-1136. (Pubitemid 38857996)
119. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008; 133: 599-609. (Pubitemid 351367366)
120. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65. (Pubitemid 38096162)
121. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR,. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907. (Pubitemid 29519356)
122. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119: 817-825. (Pubitemid 46527825)
123. Murphy KR, Zeiger RS, Kosinski M, Chipps B, Mellon M, Schatz M, et al. Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol 2009; 123: 833-839.
124. Wildfire JJ, Gergen PJ, Sorkness CA, Mitchell HE, Calatroni A, Kattan M, et al. Development and validation of the Composite Asthma Severity Index-an outcome measure for use in children and adolescents. J Allergy Clin Immunol 2012; 129: 694-701.
125. Gibson NA, Ferguson AE, Aitchison TC, Paton JY,. Compliance with inhaled asthma medication in preschool children. Thorax 1995; 50: 1274-1279.
126. Minai BA, Martin JE, Cohn RC,. Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinic. Respir Care 2004; 49: 600-605.
127. van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC,. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy 2012; 67: 265-271.
128. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR,. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-2173.
129. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB,. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009: CD006340.
130. Nuijsink M, Hop WC, Sterk PJ, Duiverman EJ, de Jongste JC,. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007; 30: 457-466. (Pubitemid 351182068)
131. Sont JK, Willems LN, Bel EH, Van Krieken JH, Vandenbroucke JP, Sterk PJ,. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 1 (Pt 1): 1043-1051. (Pubitemid 29202534)
132. Jackson DJ, Sykes A, Mallia P, Johnston SL,. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128: 1165-1174.
133. Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, et al. Viruses and bacteria in acute asthma exacerbations-a GA(2) LEN-DARE systematic review. Allergy 2011; 66: 458-468.
134. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32: 545-554.
135. FitzGerald JM, Shragge D, Haddon J, Jennings B, Lee J, Bai T, et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J 2000; 7: 61-67.
136. Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009; 360: 339-353.
137. Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007; 175: 323-329.
138. Rabe KF, Vermeire PA, Soriano JB, Maier WC,. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807. (Pubitemid 32049363)
139. Szefler SJ,. Advancing asthma care: the glass is only half full! J Allergy Clin Immunol 2011; 128: 485-494.